SKOPJE (North Macedonia), November 20 (SeeNews) - North Macedonia-based drug maker Replek [MSE:REPL] said that its consolidated net profit remained unchanged year-on-year at 85.4 million denars ($1.5 million/1.4 million euro) in the first nine months of 2019.